Developmental and Epileptic Encephalopathy Market: Strong Pharma Growth Forecast Through 2034 - DelveInsight

AI Briefing

• – Market is expected to grow at a CAGR of 4.8% from 2021 to 2034.
• – The US market is expected to account for the largest share of the global Developmental and Epileptic Encephalopathy market in 2027.
• – Key players are developing new therapies, including gene therapies and gene editing technologies, to treat Developmental and Epileptic Encephalopathy.